Health Care - As introduced, lowers from every three years to every two years, the time within which the advisory committee composed of medical device industry representatives and a representative of the department of economic and community development must review rules regarding the board of pharmacy's oversight of facilities that manufacture, warehouse, and distribute medical devices in order to review the advancements of new medical device technologies. - Amends TCA Title 8; Title 47; Title 56; Title 63 and Title 71.

Latest action: Taken off notice for cal in s/c Finance, Ways, and Means Subcommittee of Finance, Ways, and Means Committee

Voted 4/15/2026

Roll-call record

How representatives voted

0 yea·0 nay

No roll-call votes recorded for this bill yet.

Docket history

4/15/2026Taken off notice for cal in s/c Finance, Ways, and Means Subcommittee of Finance, Ways, and Means Committee
4/9/2026Placed on s/c cal Finance, Ways, and Means Subcommittee for 4/14/2026
3/11/2026Placed behind the budget
3/4/2026Placed on s/c cal Finance, Ways, and Means Subcommittee for 3/11/2026
3/4/2026Sponsor(s) Added.
3/4/2026Assigned to s/c Finance, Ways, and Means Subcommittee
3/2/2026Sponsor(s) Added.
3/2/2026Rec. for pass; ref to Finance, Ways, and Means Committee
2/25/2026Placed on cal. Government Operations Committee for 3/2/2026
2/17/2026Rec. for pass. if am., ref. to Government Operations Committee